118 related articles for article (PubMed ID: 11695553)
1. Comparison of the levels of enzymes involved in drug metabolism between transgenic or gene-knockout and the parental mice.
Ariyoshi N; Imaoka S; Nakayama K; Takahashi Y; Fujita K; Funae Y; Kamataki T
Toxicol Pathol; 2001; 29 Suppl():161-72. PubMed ID: 11695553
[TBL] [Abstract][Full Text] [Related]
2. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
[TBL] [Abstract][Full Text] [Related]
3. Xpa and Xpa/p53+/- knockout mice: overview of available data.
van Kreijl CF; McAnulty PA; Beems RB; Vynckier A; van Steeg H; Fransson-Steen R; Alden CL; Forster R; van der Laan JW; Vandenberghe J
Toxicol Pathol; 2001; 29 Suppl():117-27. PubMed ID: 11695547
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of hormonal carcinogenesis in the p53+/- hemizygous knockout mouse: studies with diethylstilbestrol.
Carmichael PL; Mills JJ; Campbell M; Basu M; Caldwell J
Toxicol Pathol; 2001; 29 Suppl():155-60. PubMed ID: 11695552
[TBL] [Abstract][Full Text] [Related]
5. Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrying human prototype c-Ha-ras gene and their wild type littermates.
Ohnishi Y; Arai T; Koshirakawa M; Horii N; Nakajo S; Urano K; Usui T; Tamaoki N; Ueyama Y
Exp Anim; 2001 Jan; 50(1):33-9. PubMed ID: 11326421
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
[TBL] [Abstract][Full Text] [Related]
7. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
8. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
[TBL] [Abstract][Full Text] [Related]
11. Hepatic drug metabolizing enzymes induced by clofibrate in rasH2 mice.
Katsutani N; Sekido T; Aoki T; Sagami F
Toxicol Lett; 2000 Jun; 115(3):223-9. PubMed ID: 10814892
[TBL] [Abstract][Full Text] [Related]
12. Expression of glutathione S-transferases in fetal lung and liver tissue from parental strains and F1 crosses between C57BL/6 and BALB/c F1 mice following in utero exposure to 3-methylcholanthrene.
Xu M; Moore JE; Leone-Kabler S; McCoy TP; Swank A; Nelson GB; Ross JA; Townsend AJ; Miller MS
Biochem Pharmacol; 2006 Jun; 72(1):115-23. PubMed ID: 16678797
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor.
Kakizaki S; Yamazaki Y; Kosone T; Horiguchi N; Sohara N; Sato K; Takagi H; Yoshinari K; Mori M
Liver Int; 2007 Feb; 27(1):109-19. PubMed ID: 17241389
[TBL] [Abstract][Full Text] [Related]
14. Evaluation on carcinogenicity of chemicals using transgenic mice.
Mitsumori K
Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
[TBL] [Abstract][Full Text] [Related]
15. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
16. Comparative xenobiotic metabolism between Tg.AC and p53+/- genetically altered mice and their respective wild types.
Sanders JM; Burka LT; Chanas B; Matthews HB
Toxicol Sci; 2001 May; 61(1):54-61. PubMed ID: 11294974
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
18. Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor.
Yanagiba Y; Ito Y; Kamijima M; Gonzalez FJ; Nakajima T
Toxicol Sci; 2009 Sep; 111(1):19-26. PubMed ID: 19525444
[TBL] [Abstract][Full Text] [Related]
19. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.
Lehman-McKeeman LD; Johnson DR; Caudill D
Toxicol Appl Pharmacol; 1997 Jan; 142(1):169-77. PubMed ID: 9007046
[TBL] [Abstract][Full Text] [Related]
20. The influence of diet composition on phase I and II biotransformation enzyme induction.
Rudolf JL; Bauerly KA; Tchaparian E; Rucker RB; Mitchell AE
Arch Toxicol; 2008 Dec; 82(12):893-901. PubMed ID: 18488195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
